Investing IdeasBrowse All StocksMarkets

Have your own idea? Try our Stock Screener

Header cover image

Singaporean (SGX) Pharma Industry Analysis

UpdatedJan 11, 2025
DataAggregated Company Financials
Companies4
  • 7D0.04%
  • 3M4.0%
  • 1Y14.4%
  • YTD-0.2%

The Pharma industry is up 1.0% in the last week, with Haw Par up 1.6%. This means that the industry has gained 15% over the past year. Looking forward, earnings are forecast to grow by 6.7% annually.

Industry Valuation and Performance

Has the Singaporean Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 11 Jan 2025S$2.6bS$449.4mS$232.7m9.6x11.2x5.8x
Mon, 09 Dec 2024S$2.6bS$449.3mS$232.7m9.6x11.4x5.9x
Wed, 06 Nov 2024S$2.5bS$448.3mS$232.7m9.3x10.8x5.6x
Fri, 04 Oct 2024S$2.5bS$448.3mS$232.7m9.4x10.8x5.6x
Sun, 01 Sep 2024S$2.4bS$438.1mS$232.2m9.2x10.2x5.4x
Tue, 30 Jul 2024S$2.4bS$431.9mS$216.0m9.7x11.3x5.6x
Thu, 27 Jun 2024S$2.3bS$432.0mS$216.0m9.3x10.6x5.3x
Sat, 25 May 2024S$2.3bS$432.0mS$216.0m9.4x10.6x5.3x
Mon, 22 Apr 2024S$2.3bS$417.3mS$214.6m9.8x10.6x5.4x
Wed, 20 Mar 2024S$2.2bS$417.2mS$214.6m10x10.4x5.4x
Fri, 16 Feb 2024S$2.2bS$371.3mS$172.1m12.5x13.1x6.1x
Sun, 14 Jan 2024S$2.3bS$371.0mS$172.1m12.6x13.2x6.1x
Tue, 12 Dec 2023S$2.3bS$371.1mS$172.1m12.4x13.2x6.1x
Thu, 09 Nov 2023S$5.0bS$1.5bS$310.2m9.9x16.2x3.3x
Sat, 07 Oct 2023S$5.5bS$1.5bS$326.9m9.7x16.9x3.6x
Mon, 04 Sep 2023S$5.5bS$1.6bS$327.8m10.2x16.8x3.5x
Wed, 02 Aug 2023S$5.8bS$1.5bS$289.9m11.1x20.1x3.8x
Fri, 30 Jun 2023S$6.2bS$1.5bS$288.3m10.7x21.5x4.1x
Sun, 28 May 2023S$7.2bS$1.6bS$292.1m11.7x24.5x4.6x
Tue, 25 Apr 2023S$6.0bS$1.6bS$268.4m13.2x22.5x3.9x
Thu, 23 Mar 2023S$5.6bS$1.4bS$264.9m9x21.1x4x
Sat, 18 Feb 2023S$5.8bS$1.4bS$251.7m9.7x23.2x4.2x
Mon, 16 Jan 2023S$5.2bS$1.4bS$265.9m8.6x19.5x3.7x
Wed, 14 Dec 2022S$5.0bS$1.4bS$261.0m8.2x19.3x3.7x
Fri, 11 Nov 2022S$4.8bS$1.3bS$253.6m11x19x3.7x
Sun, 09 Oct 2022S$4.4bS$1.3bS$247.1m10.7x17.8x3.3x
Tue, 06 Sep 2022S$4.8bS$1.4bS$250.5m11x19.3x3.6x
Thu, 04 Aug 2022S$4.7bS$1.3bS$228.4m10.1x20.7x3.6x
Sat, 02 Jul 2022S$5.0bS$1.3bS$229.3m10.4x21.7x3.7x
Mon, 30 May 2022S$4.8bS$1.3bS$228.2m10.7x20.9x3.6x
Wed, 27 Apr 2022S$4.7bS$1.3bS$232.7m12.5x20.1x3.5x
Fri, 25 Mar 2022S$5.5bS$1.4bS$248.3m11.9x22x3.9x
Sun, 20 Feb 2022S$5.4bS$1.4bS$219.7m14.4x24.8x4x
Tue, 18 Jan 2022S$5.9bS$1.3bS$212.7m14.9x27.6x4.4x
Price to Earnings Ratio

27.6x


Total Market Cap: S$5.9bTotal Earnings: S$212.7mTotal Revenue: S$1.3bTotal Market Cap vs Earnings and Revenue0%0%0%
Singaporean Pharma Industry Price to Earnings3Y Average 17x202320242025
Current Industry PE
  • Investors are pessimistic on the Singaporean Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 11.3x which is lower than its 3-year average PE of 17.1x.
  • The 3-year average PS ratio of 4.4x is lower than the industry's current PS ratio of 5.8x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 3.1% per year over the last three years.
  • Meanwhile revenues for these companies have declined 30% per year.
  • This means that less sales are being generated overall, but since cost of doing business is lower, profits have been increasing.

Industry Trends

Which industries have driven the changes within the Singaporean Healthcare industry?

SG Market-0.46%
Healthcare0.45%
Pharma0.04%
Pharma0.04%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
H02 Haw ParS$11.140.09%
+S$2.2m		15.4%PE10.5x
1J5 Hyphens Pharma InternationalS$0.291.8%
+S$1.5m		1.8%PE8.6x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlans & PricingLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

H02

S$11.14

Haw Par

7D

0.09%

1Y

15.4%

Investors Holding Back On Haw Par Corporation Limited (SGX:H02)

Dec 19
Investors Holding Back On Haw Par Corporation Limited (SGX:H02)

42C

S$0.024

iX Biopharma

7D

-7.7%

1Y

-48.9%

BFK

S$0.55

Pharmesis International

7D

-5.2%

1Y

518.0%

Is Pharmesis International (SGX:BFK) Using Too Much Debt?

Oct 10
Is Pharmesis International (SGX:BFK) Using Too Much Debt?

1J5

S$0.29

Hyphens Pharma International

7D

1.8%

1Y

1.8%